Shadd Dales breaks down a major development out of Washington as President Donald Trump signs a new executive order aimed at accelerating psychedelic medicine research in the United States.
Shadd Dales is the Founder and President of The Dales Report. With over 15 years of experience in mainstream media, he is recognized as a leading on-air talent in the cannabis and psychedelic sectors, focusing on topics such as psychedelic research, therapy, and cannabis business and regulation. Shadd's insights and expertise have been featured in Benzinga, The Dales Report, and The Business Herald.














